Somatostatin and vasoactive intestinal polypeptide in the cerebrospinal fluid of patients with neurological disorders
Shimatsu, A.; Kato, Y.; Tatsuoka, Y.; Yoshida, K.; Imura, H.
Rinsho Shinkeigaku 25(11): 1305-1310
1985
ISSN/ISBN: 0009-918X PMID: 2871957 Document Number: 242913
Document emailed within 1 workday
Related Documents
Crivellato, E.; Damiani, D.; Mallardi, F.; Travan, L. 1991: Suggestive evidence for a microanatomical relationship between mast cells and nerve fibres containing substance P, calcitonin gene related peptide, vasoactive intestinal polypeptide, and somatostatin in the rat mesentery Acta Anatomica 141(2): 127-131Murayama, T.; Matsuoka, Y.; Takahashi, A.; Asano, T.; Kato, K. 1988: Concentration of the alpha subunit of GTP-binding protein G0 in the cerebrospinal fluid of patients with neurological disorders Rinsho Shinkeigaku 28(5): 525-531
Beretti, F.; Pietrosemoli, P.; Bartoletti, A.Maria.; Rondini, I.; Portolani, M. 2006: Cerebrospinal fluid samples from patients with various neurological disorders have a transmissible cytotoxic activity with similar properties New Microbiologica 29(2): 143-146
Taj, A.; Jamil, N. 2016: Detection of meningococcal meningitis in cerebrospinal fluid of patients with neurological disorders in government hospitals of Karachi Jpma. Journal of the Pakistan Medical Association 66(11): 1418-1421
Carlquist, M.; Jörnvall, H.; Tatemoto, K.; Mutt, V. 1982: A porcine brain polypeptide is identical to the vasoactive intestinal polypeptide Gastroenterology 83(1 Part 2): 245-249
Whitaker, J.N.; Lisak, R.P.; Bashir, R.M.; Krance, R.; Lawrence, J.A.; Ch'ien, L.T.; O'Sullivan, P. 1978: Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders Transactions of the American Neurological Association 103: 212-215
Giordano, C.; Clerc, M.; Doutriaux, C.; Piquemal, M. 1977: Cerebrospinal fluid gamma globulins in neurological disorders affecting black Africans La Nouvelle Presse Medicale 6(36): 3305-3308
Varsky, C.G. 1978: Vasoactive intestinal polypeptide (V.I.P) Acta Gastroenterologica Latinoamericana 8(2): 139-170
Iwanaga, T. 2002: Vasoactive intestinal polypeptide (VIP) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 6): 35-38
Tomkin, G.H.; Ardill, J.; Lafferty, H.; Darragh, A. 1983: Vasoactive intestinal polypeptide in obesity International Journal of Obesity 7(2): 153-160
Wiederkehr, F.; Vonderschmitt, D.J. 1985: 2-dimensional electrophoresis of cerebrospinal fluid in various neurological patients Schweizerische Medizinische Wochenschrift 115(11): 368-373
Tagami, T. 1970: Disc electrophoretic analysis of cerebrospinal fluid proteins in the disturbances of optic nerve. I. Comparison of cerebrospinal fluid at various sites in the cerebrospinal axis. With special reference to the cerebrospinal fluid in the chiasmatic cistern Nippon Ganka Gakkai Zasshi 74(9): 1129-1135
Maruyama, I.; Igata, A. 1979: Plasminogen concentration in the cerebrospinal fluid of patients with various neurological diseases Rinsho Shinkeigaku 19(8): 481-485
Suga, H.; Fujiyoshi, K.; Okamoto, K.; Nakamura, S.; Kameyama, M. 1984: Measurement of methionine-enkephalin-like immunoreactivity in the cerebrospinal fluid of various neurological patients Rinsho Shinkeigaku 24(9): 867-871
Unverferth, D.V.; O'Dorisio, T.M.; Muir, W.W.; White, J.; Miller, M.M.; Hamlin, R.L.; Magorien, R.D. 1985: Effect of vasoactive intestinal polypeptide on the canine cardiovascular system Journal of Laboratory and Clinical Medicine 106(5): 542-550
Levy, J.A.; Shimabukuro, J.; Hollander, H.; Mills, J.; Kaminsky, L. 1985: Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms Lancet 2(8455): 586-588
Haghjoo, K.; Cash, P.W.; Farid, R.S.; Komisaruk, B.R.; Jordan, F.; Pochapsky, S.S. 1996: Solution structure of vasoactive intestinal polypeptide (11-28)-NH2, a fragment with analgesic properties Peptide Research 9(6): 327-331
Ryan, J.; Cohen, S. 1977: Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure Gastroenterology 73(4 Pt 1): 870-872
Basterra, J.; Dilly, P.N.; Perez, M.; Chumbley, C.C. 1989: Vasoactive intestinal polypeptide and neuropeptide-Y, as possible mediators in laryngeal oedema. An immunofluorescence study Acta Oto-Rhino-Laryngologica Belgica 43(2): 99-104
Hara, N.; Yosida, T.; Said, S.I. 1978: Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction Nihon Kyobu Shikkan Gakkai Zasshi 16(11): 840-845